BeStock  
Stocks › Biotechnology › MRVI

Maravai LifeSciences MRVI

US equityMarket cap rank #3127Biotechnology
$6.98 −$0.21 (-2.92%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.98 0.00%
Open$7.06
Prev close$7.19
Day range$6.91 – $7.17
Volume1.79M
Market cap$1.04B
P/E (TTM)–
Dividend yield–

MRVI Stock News

Headlines matching Maravai LifeSciences or the MRVI ticker, most recent first.

  • Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy RatingMarket news · 16 Sep 2026 · Direct mention
  • William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold RatingMarket news · 7 Aug 2026 · Direct mention
  • Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $8 PositiveMarket news · 13 Aug 2026 · Direct mention
  • Deutsche Bank Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $6 NegativeMarket news · 8 May 2026 · Direct mention
  • Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $5Market news · 8 May 2026 · Direct mention
  • William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Announces Target Price $3.94Market news · 8 May 2026 · Direct mention
  • Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $6 PositiveMarket news · 12 May 2026 · Direct mention
  • Guggenheim Maintains Maravai LifeSciences(MRVI.US) With Hold RatingMarket news · 11 May 2026 · Direct mention
  • Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4Market news · 28 Feb 2026 · Direct mention
  • Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $10Market news · 5 Nov 2026 · Direct mention
  • Earnings Flash (MRVI) Maravai LifeSciences Holdings, Inc. Posts Q3 Adjusted Loss $0.03 per Share, Vs. FactSet Est of $-0.06 NegativeMT Newswires · 5 Nov 2026 · Direct mention
  • Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Raises Target Price to $9.5 PositiveMarket news · 5 Nov 2026 · Direct mention
  • KeyBanc Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $11Market news · 12 Nov 2026 · Direct mention
  • TD Cowen Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $9Market news · 5 Oct 2026 · Direct mention
  • Wells Fargo Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $4Market news · 13 Aug 2025 · Direct mention

Discussion

No comments yet — be the first to weigh in on MRVI.

Sign in to join the discussion.

Scroll to Top